1. Bill Gates, co-founder of Microsoft, urged businesses and other entities to invest in research and development of medical products for children in developing countries during an event in Tokyo.
2. Gates emphasized that the benefits of such research extend beyond the company or entity doing the work, stating "The returns to research go way beyond the company that does that work. The benefits to society are huge."
3. Gates highlighted the challenge his foundation faces in terms of funding for its efforts to address health problems in developing countries and emphasized the importance of continued international support, saying "Health is a win, win. Any drug that Japan discovers benefits the entire world."
2. Gates emphasized that the benefits of such research extend beyond the company or entity doing the work, stating "The returns to research go way beyond the company that does that work. The benefits to society are huge."
3. Gates highlighted the challenge his foundation faces in terms of funding for its efforts to address health problems in developing countries and emphasized the importance of continued international support, saying "Health is a win, win. Any drug that Japan discovers benefits the entire world."
Similar Readings (5 items)
Bill Gates calls for active R&D of drugs to help children in developing nations
Bill Gates to donate most of his wealth by 2045 to save and improve lives
summary of Bill Gates calls for active R&D of drugs to help children in developing nations
Bill Gates: Japan can play big role in fight against infectious diseases
Summary: Bill Gates’s old climate lobbyists launch a new firm
Summary
Bill Gates, Microsoft co-founder, urged investment in medical research for children in developing countries. He emphasized the societal benefits of such research, stating that "The returns to research go way beyond the company that does that work." Gates highlighted the challenge his foundation
Reading History
| Date | Name | Words | Time | WPM |
|---|---|---|---|---|
| 2025/08/22 07:15 | Anonymous | 0 | - | - |